George N. Tzanakakis - Histology

Author Information

George N. Tzanakakis is affiliated with the Laboratory of Anatomy-Histology-Embryology, Medical School, University of Crete, located in Heraklion, Crete, Greece. His research work spans across various domains of histology and oncology, particularly focusing on extracellular matrix components and their role in cancer progression and development.

Research Contributions

George N. Tzanakakis has made significant contributions to the understanding of extracellular matrix components such as biglycan and lumican, and their interactions with signaling pathways like IGF-IR in the context of cancer. His research also explores the pathogenesis of hormone-dependent cancers and the potential of glycosaminoglycans as carriers and targets for anti-cancer therapy. Additionally, his work delves into the biocompatibility of nanoparticles for drug delivery in cancer treatment.

Aliases

George N. Tzanakakis is also known by several aliases including G N Tzanakakis, George N Tzanakakis, G. N. Tzanakakis, G. Tzanakakis, and George Tzanakakis.

Publication and Citation Metrics

Metric	Value
Total Citation Count	7315
h-index	48
Total Paper Count	172

Publications:

Preface of the Special Issue on the Role of Extracellular Matrix in Development and Cancer Progression

DOI: 10.3390/biom12030362

Year: 2022

Biglycan Interacts with Type I Insulin-like Receptor (IGF-IR) Signaling Pathway to Regulate Osteosarcoma Cell Growth and Response to Chemotherapy

DOI: 10.3390/cancers14051196

Year: 2022

Lumican in Carcinogenesis—Revisited

DOI: 10.3390/biom11091319

Year: 2021

The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis

DOI: 10.3390/cancers13102478

Year: 2021

Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy

DOI: 10.3390/biom11030395

Year: 2021

Assessment of amphiphilic poly-N-vinylpyrrolidone nanoparticles' biocompatibility with endothelial cells in vitro and delivery of anti-inflammatory drug.

DOI: 10.1021/acs.molpharmaceut.0c00667

Year: 2020

Proteoglycans in the Pathogenesis of Hormone-Dependent Cancers: Mediators and Effectors

DOI: 10.3390/cancers12092401

Year: 2020

Lumican mediates HTB 94 chondrosarcoma cell growth via an IGF ‐ IR / Erk 1 / 2 axis

DOI:

Year: 2020

Lumican mediates HTB94 chondrosarcoma cell growth via an IGF-IR/Erk1/2 axis

DOI: 10.3892/ijo.2020.5094

Year: 2020

Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements

DOI: 10.3390/cells8101251

Year: 2019

Can Reagents Be Rejuvenated?

What is the American Association for the Advancement of Science (AAAS)?

What Triggers Fibrosis?

What are Saturated Fats?

What Are the Benefits of Combining Manometry with Histology?

What are the main layers of the GI tract?

What is the Role of AI in Histology?

What are the Effects of UV Radiation on Skin Cells?

How do Ribonucleases Affect Histological Techniques?

What is a Trichogram?

Partnered Content Networks

Relevant Topics